Tag: BE OPTIMAL

Meet the Trialist: Prof. Philip J. Mease on the bimekizumab clinical trial program in psoriatic arthritis

Expert
Prof. Philip J. Mease, Swedish Medical Center/Providence-St. Joseph Health, Seattle, WA, USA
Trial
Phase 3, BE OPTIMAL, BE COMPLETE, BE VITAL
Conference
ACR 2024

23 December 2024 14:39

Biologics in psoriatic arthritis: where we are and where we are headed

Presented By
Dr Vinod Chandran
Conference
IFPA 2024
Type
News article

17 July 2024 11:55

Dual IL-17 blockade yields efficacy on joints and skin

Presented By
Prof. Diamant Thaçi, University of Lübeck, Germany
Trial
Phase 3, BE OPTIMAL; BE COMPLETE
Conference
EADV 2023
Type
Peer-reviewed article

28 November 2023 12:27

Bimekizumab: high rates of sustained response in PsA

Trial
Phase 3, BE OPTIMAL
Conference
EULAR 2023
Type
Peer-reviewed article

31 July 2023 06:46

EULAR 2022 Highlights Podcast

Presented By
Dr Rachel Giles, Medicom
Conference
EULAR 2022

22 June 2022 23:51
site created by:   

© 2024 Medicom Medical Publishers.  All rights reserved. Terms and Conditions | Privacy Policy



HEAD OFFICE
Laarderhoogtweg 25
1101 EB Amsterdam
The Netherlands
T: +31 85 4012 560
E: publishers@medicom-publishers.com